Literature DB >> 10474562

Blood pressure level and incidence of myocardial infarction among patients treated for hypertension.

R C Kaplan1, B M Psaty, S R Heckbert, N L Smith, R N Lemaitre.   

Abstract

OBJECTIVES: This study examined the relationship between achieved blood pressure and risk of myocardial infarction among patients treated for hypertension.
METHODS: Blood pressure and other cardiovascular risk factors were assessed among 718 myocardial infarction case patients and 2136 matched controls.
RESULTS: Blood pressure level was directly related to risk of myocardial infarction. Patients with treated hypertension who had mild elevations in blood pressure accounted for a larger share of the excess myocardial infarction incidence than those who had higher blood pressure readings.
CONCLUSIONS: Achieving normotensive levels in treated hypertensive patients with uncontrolled blood pressure might prevent more than 15% of myocardial infarctions in the treated hypertensive population.

Entities:  

Mesh:

Year:  1999        PMID: 10474562      PMCID: PMC1508771          DOI: 10.2105/ajph.89.9.1414

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  9 in total

1.  Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators.

Authors:  F Gueyffier; F Boutitie; J P Boissel; S Pocock; J Coope; J Cutler; T Ekbom; R Fagard; L Friedman; M Perry; R Prineas; E Schron
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

2.  Confounding and misclassification.

Authors:  S Greenland; J M Robins
Journal:  Am J Epidemiol       Date:  1985-09       Impact factor: 4.897

3.  Case-control study of stroke and the quality of hypertension control in north west England.

Authors:  X Du; K Cruickshank; R McNamee; M Saraee; J Sourbutts; A Summers; N Roberts; E Walton; S Holmes
Journal:  BMJ       Date:  1997-01-25

4.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  V L Burt; P Whelton; E J Roccella; C Brown; J A Cutler; M Higgins; M J Horan; D Labarthe
Journal:  Hypertension       Date:  1995-03       Impact factor: 10.190

5.  Need to prevent and control high-normal and high blood pressure, particularly so-called "mild" hypertension: epidemiological and clinical data.

Authors:  D Giumetti; K Liu; R Stamler; J A Schoenberger; R B Shekelle; J Stamler
Journal:  Prev Med       Date:  1985-07       Impact factor: 4.018

6.  Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991.

Authors:  V L Burt; J A Cutler; M Higgins; M J Horan; D Labarthe; P Whelton; C Brown; E J Roccella
Journal:  Hypertension       Date:  1995-07       Impact factor: 10.190

7.  The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?

Authors:  L Farnett; C D Mulrow; W D Linn; C R Lucey; M R Tuley
Journal:  JAMA       Date:  1991 Jan 23-30       Impact factor: 56.272

8.  The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women.

Authors:  B M Psaty; S R Heckbert; D Atkins; R Lemaitre; T D Koepsell; P W Wahl; D S Siscovick; E H Wagner
Journal:  Arch Intern Med       Date:  1994-06-27

9.  Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias.

Authors:  S MacMahon; R Peto; J Cutler; R Collins; P Sorlie; J Neaton; R Abbott; J Godwin; A Dyer; J Stamler
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

  9 in total
  5 in total

Review 1.  Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.

Authors:  Hedi Schelleman; Bruno H Ch Stricker; Anthonius De Boer; Abraham A Kroon; Monique W M Verschuren; Cornelia M Van Duijn; Bruce M Psaty; Olaf H Klungel
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  Cardiovascular-related healthcare resource utilization and costs in patients with hypertension switching from metoprolol to nebivolol.

Authors:  Stephanie Chen; An-Chen Fu; Rahul Jain; Hiangkiat Tan
Journal:  Am Health Drug Benefits       Date:  2015-04

3.  Recruitment of participants through community pharmacies for a pharmacogenetic study of antihypertensive drug treatment.

Authors:  Diane B M A van Wieren-de Wijer; Anke-Hilse Maitland-van der Zee; Anthonius de Boer; Bruno H Ch Stricker; Abraham A Kroon; Peter W de Leeuw; O Bozkurt; Olaf H Klungel
Journal:  Pharm World Sci       Date:  2008-11-30

4.  Blood pressure control and risk of incident atrial fibrillation.

Authors:  M C Thomas; S Dublin; R C Kaplan; N L Glazer; T Lumley; W T Longstreth; N L Smith; B M Psaty; D S Siscovick; S R Heckbert
Journal:  Am J Hypertens       Date:  2008-08-28       Impact factor: 2.689

5.  Adverse Reaction of Acupuncture and Antihypertensive Drugs for Treatment of Essential hypertension: A Protocol for Bayesian Network Meta-Analysis.

Authors:  Jiawei Han; Jiwei Yang; Yuanhao Du
Journal:  Comput Intell Neurosci       Date:  2022-08-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.